More than 1 billion doses of Xinguan vaccine have been inoculated in China

Guangming Daily, Beijing, June 20 (reporter Jin Zhenya) - as of June 19, 31 provinces (autonomous regions and municipalities directly under the central government) and Xinjiang production and Construction Corps have reported over 1 billion doses of new crown vaccine.

Novel coronavirus pneumonia was officially launched in December 15, 2020 in order to effectively prevent and control the new crown pneumonia epidemic. In late March this year, China began to speed up the promotion of free vaccination for the whole population, from high-risk, key groups to the general population.

As of March 23, a total of 82.846 million doses of Xinguan vaccine had been reported. On March 24, China launched the "daily report system" of new crown vaccination. From 100 million doses to 200 million doses, it took 25 days, and then the speed gradually accelerated, from 900 million doses to 1 billion doses, it only took 5 days.

Zeng Yixin, deputy director of the National Health Commission and head of the vaccine research and development team of the joint prevention and control mechanism of the State Council, once introduced at the press conference of the national information office that China adheres to early deployment and multiple routes, and the speed and quantity of new crown vaccine research and development has always been in the first place in the world. In the process of vaccine development and production, we always put the safety and effectiveness of vaccine in the first place.

For the 3 to 17 years of age, whether the population can be vaccinated, Cui Gang, two inspector of the national health authority's Disease Control Bureau, said that at present, China's new crown vaccination is mainly carried out among the people over 18 years of age. The relevant state departments have approved the urgent use of COVID-19 inactivated vaccine among people aged 3 to 17. According to the epidemic situation, the needs of prevention and control work and the characteristics of the relevant population, the state will organize experts to study and formulate specific policies for the vaccination of people aged 3 to 17.

In response to the public's concern about the adverse reactions caused by vaccination, the China Center for Disease Control and Prevention (CDC) released the monitoring of adverse reactions in China's new crown vaccination on May 28. The interpretation provided by the center shows that the incidence of general and abnormal reactions of new crown vaccines in China is lower than the average reported level of other vaccines in 2019. At present, it is estimated that the incidence of severe adverse reactions is very low, and the benefits of vaccination are far greater than the risks. Countries are continuing to promote vaccination.

Experts said that the recent local cases showed that the prevention and control situation is still grim, and the transmission ability of the mutant strains found abroad is enhanced, but the existing vaccines in China still have considerable protective effect on the mutant virus. In the case of mass immunization has not yet been established, whether or not vaccinated with new crown vaccine, wearing masks should become the daily "standard".